Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | BC3402 |
Trade Name | |
Synonyms | BC 3402|BC-3402 |
Drug Descriptions |
BC3402 is a monoclonal antibody targeting TIM-3, which potentially enhances antitumor immune response (Cancer Res (2024) 84 (7_Supplement): CT185, NCI Thesaurus). |
DrugClasses | TIM-3 Antibody 9 |
CAS Registry Number | NA |
NCIT ID | C200196 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
BC3402 | BC3402 | 0 | 0 |
BC3402 + Durvalumab + Tremelimumab | BC3402 Durvalumab Tremelimumab | 0 | 1 |